Market success of Novo Nordisk’s obesity drug likely to be delayed in Japan, says GlobalData

In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1

GenWorks introduces mechanical hysteroscopic tissue removal system

Uses a simple mechanical approach for removing intrauterine tissues

Lupin Digital Health and American College of Cardiology collaborate for in-home cardiovascular care in India

TransCure bioServices partners with Preclina to expands reach into APAC

Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders

Syngene Q1 FY 2024 revenue up 26% to Rs. 832 crores, PAT up 26% to Rs.93 Cr

Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24

NATCO files generic Erdafitinib Tablets in USA

Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma

Need to strengthen food safety scientific standards: NITI Aayog

There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits

ABDM supports the integration of digital health infrastructure

Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations

13.91 crore teleconsultations have been completed:PIB

1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women

Lupin receives tentative USFDA’s approval for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets

This product would be manufactured at Lupin's Nagpur facility in India